Reinforced NVG-291's broad therapeutic potential with new data across three distinct injury models Vancouver, British Columbia--(Newsfile Corp. - August 21, 2025) - NervGen Pharma Corp. (TSXV: NGEN) ...
Vancouver, British Columbia--(Newsfile Corp. - September 30, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative solutions for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback